Sanguina, Inc.

Sanguina, Inc. — FDA 510(k) Submissions

Sanguina, Inc. has submitted 1 FDA 510(k) premarket notifications since 2023, of which 1 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Whole Blood Hemoglobin Determination . Use the specialty filter in the sidebar to narrow results.